At CVS Health®, we’re committed to encouraging the adoption of high-quality, affordable medications, including biosimilar drugs. Access to biosimilars — medications that can treat many chronic and severe conditions — is critical for patients who may need them. Biosimilars can treat everything from specific types of cancers to diabetes, and they present one of the biggest opportunities for controlling drug costs in today’s health care system.
A new report authored by Sree Chaguturu, MD, Executive Vice President and Chief Medical Officer, CVS Health, explains how biosimilar drugs help make treatments more affordable. It also showcases how Cordavis™, a CVS Healthspire™️ company, focused on manufacturing high-quality biosimilars, is improving patient access to these life-changing treatments and bringing innovation to health care.
